Nature's Sunshine Q4 net income triples to $9.0M; full-year 2023 adjusted EBITDA up 26%

NATURES SUNSHINE PRODUCTS INC

Q4 net sales $108.9M, up 6% YoY; North America sales up 12.8%. GAAP EPS $0.46 vs $0.10.
Full year 2023 net sales $445.3M (+5.5%); GAAP net income $15.1M vs loss $0.4M in 2022.
Q4 adjusted EBITDA $9.7M (+21%); full-year adjusted EBITDA $40.4M (+26%).
FY 2024 outlook: net sales $455-$480M, adjusted EBITDA $42-$48M.
No outstanding debt, cash $82.4M; repurchased 424K shares for $6.4M in 2023.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NATURES SUNSHINE PRODUCTS INC reported the fourth quarter and full year ended December 31, 2023 results: revenue $108.9 million, net income $9.0 million, or $0.46 per diluted share, EPS $0.46 per diluted share.

Period: the fourth quarter and full year ended December 31, 2023
Revenue: $108.9 million
Net income: $9.0 million, or $0.46 per diluted share
EPS: $0.46 per diluted share
Result: reported results

Exact text from the filing

financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights vs. Same Year-Ago Quarter • Net sales were up 6.0% to $108.9 million compared to $102.7 million (up 5.6% in constant currency). • GAAP net income attributable to common shareholders up significantly to $9.0 million, or $0.46 per diluted share,

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

NATURES SUNSHINE PRODUCTS INC filing history →

Source: SEC EDGAR

accession 0001628280-24-010566

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.